Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver disease.
Yi-Ting ChenTzu-I ChenSzu-Ching YinChia-Wei HuangJee-Fu HuangSheng-Nan LuMing-Lun YehChung-Feng HuangChia-Yen DaiYu-Wei ChenWan-Long ChuangMing-Lung YuMei-Hsuan LeePublished in: Journal of gastroenterology and hepatology (2024)
Individuals with MASLD and elevated liver enzyme levels exhibited significantly higher risks of all-cause and cardiometabolic deaths and should be monitored and given consultation on cardiometabolic modifications.